Why Federal Agencies Are Targeting Executives

Send us Fan MailFederal enforcement is changing. Regulators aren’t just going after companies anymore. They’re naming CEOs, CMOs, heads of clinical, quality, and operations in consent decrees and injunctions. Once your name is on that document, it follows you for years and shapes your career.In this episode we unpack:Why enforcement has shifted toward individual accountabilityHow repeated compliance failures trigger personal liabilityData integrity and why it matters more than everWhy clinical research and telehealth are now in regulators’ crosshairsWhat personal obligations look like inside a consent decreeWhat executives should be doing now to protect themselvesIf you lead in an FDA-regulated space, this one matters.Get show notes and resources at www.kulkarnilawfirm.comSubscribe for weekly breakdowns of enforcement trends that actually affect you.Support the showwww.kulkarnilawfirm.com